Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free!Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Designed under ISO 9001:2015 and ISO 13485:2016
Manufactured and QC tested under a GMP compliance factory
Animal-Free materials
Beta-lactam materials free
Batch-to-batch consistency
Stringent quality control tests
This protein carries no "tag".
The protein has a calculated MW of 17.5 kDa. The protein migrates as 18 kDa±3 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE).
>95% as determined by SDS-PAGE.
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with protectants.
Contact us for customized product form or formulation.
This product is supplied and shipped with blue ice, please inquire the shipping cost.
Upon receipt, store it immediately at -20°C or lower for long term storage.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
GMP Human IL-1 beta Protein on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).
ACROBiosystems GMP grade products are produced under a quality management system and in compliance with relevant guidelines: Ph. Eur General Chapter 5.2.12 Raw materials of biological origin for the production of cell-based and gene therapy medicinal products; USP<92>Growth Factors and Cytokines Used in Cell Therapy Manufacturing; USP<1043>Ancillary Materials for Cell, Gene, and Tissue-Engineered Products; ISO/TS 20399-1:2018, Biotechnology - Ancillary Materials Present During the Production of Cellular Therapeutic Products.
ACROBiosystems Quality Management System Contents:
Designed under ISO 9001:2015 and ISO 13485:2016, Manufactured and QC tested under a GMP compliance factory.
Animal-Free materials
Materials purchased from the approved suppliers by QA
ISO 5 clean rooms and automatic filling equipment
Qualified personnel
Quality-related documents review and approve by QA
Fully batch production and control records
Equipment maintenance and calibration
Validation of analytical procedures
Stability studies conducted
Comprehensive regulatory support files
Request For Regulatory Support Files(RSF)
ACROBiosystems provide rigorous quality control tests (fully validated equipment, processes and test methods) on our GMP grade products to ensure that they meet stringent standards in terms of purity, safety, activity and inter-batch stability, and each bulk QC lot mainly contains the following specific information:
SDS-PAGE
Protein content
Endotoxin level
Residual Host Cell DNA content
Residual Host Cell Protein content
Biological activity analysis
Microbial testing
Mycoplasma testing
In vitro virus assay
Batch-to-batch consistency
Price(EUR) : €590.00
Price(EUR) :
Price(EUR) :
Explore our catalog of therapeutic antibody solutions to find the right products for you! We are dedicated to delivering solutions designed to help you drive innovation and push the boundaries of what therapeutic antibodies can be.
We offer a wide range of cell and gene therapy solutions starting from discovery to the clinic. Explore our wide range of proteins, antibodies, kits, and other assays to accelerate the development of your cell and gene therapy.
Organoid Toolbox is a collection of organoid solutions including ready-to-use organoids, organoid differentiation kits, and a variety of services to accelerate the progress of your drug development project.
ACROBiosystems developed a series of GMP grade cytokines under the GMP grade quality management system. Those products are all suitable for T/NK cell generation, activation, and proliferation in cell therapy research.
50+ targets designed for CAR detection, including PE/FITC/biotin labeled proteins. The key reagents for CD19 and BCMA were FDA DMF filed which can support your IND, NDA and BLA process.
GMP grade cytokines, reagents for cell activation, gene edition, DNA/RNA removal, etc. Particularly focus on product design, quality control and solution-based support to link each phase of your cell and gene therapy journey.
Full length multi-pass TPs with stabilized structure and high bioactivity for immunization, antibody screening, cell based assay and CAR detection, including hot CD20, Claudin 18.2, CD133, GPRC5D,CCR8, CCR5, etc.
A series of immune checkpoints including classic co-inhibitory and co-stimulatory receptors. The comprehensive catalog contains 100+ targets with various species and tags, and the high-quality proteins are in good batch-to-batch consistency.
To meet the needs of ADCs development, ACROBiosystems can provide: A variety of high-quality target proteins; MMPs/Cathepsin/uPA for cleavable linker; Anti-payload antibodies & anti-idiotypic antibodies for immunogenicity and PK analysis; SPR/BLI analytical and ADA development service.
Comprehensive collection of Fc receptor proteins, including their common variants, which can help expedite your antibody development.
Comprehensive cytokine targets including interleukins, growth factors, chemokines, TNFs, etc. are expressed by HEK293 to ensure their natural structure. Their high purity is verified by SDS-PAGE/HPLC/SEC-MALS and high bioactivity is verified by ELISA/SPR/BLI.
Aneuro provides innovative solutions for neuroscience research. Recombinant proteins, neural factors, pre-formed fibrils, electrophysiological electrodes, as well as Organoid Toolbox all in Aneuro aiming to advance neuroscience research, develop therapeutic interventions, and improve diagnostic methods for neurological diseases.
English Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Fecha | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Canakinumab | ACZ-885 | Approved | Novartis Pharma Ag | Ilaris | United States | Cryopyrin-Associated Periodic Syndromes; Muckle-Wells Syndrome (MWS) | Novartis Pharma Ag | 2009-06-17 | Gout; Hyperimmunoglobulin D syndrome; Mucocutaneous Lymph Node Syndrome; Cryopyrin-Associated Periodic Syndromes; Arthritis, Gouty; Cognitive Dysfunction; Sarcoidosis, Pulmonary; Alzheimer Disease; Urticaria; Muscular Dystrophy, Duchenne; Primary Myelofibrosis; Pulmonary Disease, Chronic Obstructive; Dry Eye Syndromes; Lung Neoplasms; Macular Degeneration; Carcinoma, Non-Small-Cell Lung; Anemia, Sickle Cell; Diabetes Mellitus; Behcet Syndrome; Aortic Aneurysm, Abdominal; Peripheral Arterial Disease; Diabetic Retinopathy; Thrombocythemia, Essential; Polycythemia Vera; Familial Mediterranean Fever; Prediabetic State; Diabetes Mellitus, Type 1; Hepatitis, Alcoholic; Schnitzler Syndrome; Atherosclerosis; Mevalonate Kinase Deficiency; Pyoderma Gangrenosum; Polyarticular Juvenile Idiopathic Arthritis; Diabetes Mellitus, Type 2; Anemia; Still's Disease, Adult-Onset; Arthritis, Rheumatoid; Small Cell Lung Carcinoma; Coronavirus Disease 2019 (COVID-19); Hereditary Autoinflammatory Diseases; Chronic Urticaria; Vasculit | Details |
PG-201 | PG-201 | Approved | Viromed | Layla | South Korea | Osteoarthritis | Pmg Pharm Co Ltd | 2012-01-01 | Osteoarthritis, Knee; Osteoarthritis | Details |
Edaravone/(+)-2-Decanol | SIM-071201; Y-2 | Approved | Jiangsu Simcere Pharmaceutical Co Ltd | Sanbexin, 三贝心, 三贝欣 | Mainland China | Stroke | Nanjing Simcere Dongyuan Pharmaceutical Co Ltd | 2020-07-29 | Intracranial Hemorrhages; Brain Infarction; Cerebral Hemorrhage; Stroke; Alzheimer Disease; Cognitive Dysfunction; Amyotrophic Lateral Sclerosis; Cognition Disorders | Details |
Diacerein | KW-4800; SF-277; Art-50 | Approved | Cartivix, Fisiodar, Verboril, Art, 安必丁, Artrodar, Artrolyt | Metabolic Dysfunction-Associated Steatotic Liver Disease; Diabetes Mellitus, Type 2; Insulin Resistance; Coronavirus Disease 2019 (COVID-19); Epidermolysis Bullosa; Osteoarthritis, Knee; Diabetes Complications; Osteoarthritis; Obesity; Osteoarthritis, Hip; Diabetes Mellitus; Overweight | Details | |||||
Andrographolide/Sodium Hydrogen Sulfite | Approved | Bacterial Infections | Details | |||||||
Rilonacept | RGN-303; KPL-914 | Approved | Regeneron Pharmaceuticals Inc | Arcalyst | United States | Cryopyrin-Associated Periodic Syndromes | Kiniksa Pharmaceuticals Ltd | 2008-02-27 | Pericarditis; Inflammation; Scleroderma, Diffuse; Renal Insufficiency, Chronic; Gout; Urticaria; Cryopyrin-Associated Periodic Syndromes; Hearing Loss, Sensorineural; Genetic Diseases, Inborn; Diabetes Mellitus, Type 1; Arthritis, Juvenile; Deficiency of interleukin-1 receptor antagonist; Scleroderma, Systemic; Muckle-Wells Syndrome (MWS); Anemia; Schnitzler Syndrome; Familial Mediterranean Fever; Still's Disease, Adult-Onset | Details |
Thalidomide | NSC-66847; NSC-527179; K-17; VP-02; FPF-300; FPF300 | Approved | Celgene Corp | Talizer, Thalidomide Celgene, Thalidomide Pharmion, Synovir, Thalomid, Thaled | Mainland China | Leprosy, Lepromatous; Multiple Myeloma | Changzhou Pharmaceutical Factory | 1982-01-01 | HIV Wasting Syndrome; Angiodysplasia; Primary Myelofibrosis; Neuroectodermal Tumors, Primitive; Prostatitis; Colorectal Neoplasms; Osteosarcoma; Lymphoma, Mantle-Cell; Sarcoma, Ewing; Retinoblastoma; Erythema Nodosum; Drug Resistant Epilepsy; Xerostomia; Sarcoma; Pancreatitis, Chronic; Adenocarcinoma, Clear Cell; Lymphoma, Follicular; Arachnoiditis; Carcinoma, Adenosquamous; Gastrointestinal Hemorrhage; Cholangitis, Sclerosing; Prostatic Neoplasms; Pelvic Pain; Neoplasm Metastasis; Stomatitis; Burning Mouth Syndrome; Mycobacterium avium-intracellulare Infection; Amyotrophic Lateral Sclerosis; Melanoma; Myelodysplastic-Myeloproliferative Diseases; Carcinoma, Hepatocellular; Leukemia, Lymphocytic, Chronic, B-Cell; Vascular Malformations; Tuberculosis; Appendiceal Neoplasms; Lymphoma, Non-Hodgkin; Uterine Neoplasms; Anemia, Sideroblastic; Glioma; Leprosy, Lepromatous; Endometrial Neoplasms; Lung Neoplasms; Waldenstrom Macroglobulinemia; Kidney Neoplasms; Thalassemia; Carcinoid Tumor; Lupus Erythematosus, Discoid | Details |
English Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Ensereptide | PXL-01 | Phase 3 Clinical | Promore Pharma | Post-surgical adhesions; Tissue Adhesions; Cicatrix | Details |
Efprezimod alfa | CD24-Fc; HAS-CD24; CD24-Fc-IgG; MK-7110; MK7110 | Phase 3 Clinical | Oncoimmune Inc | Solid tumours; Hematopoietic stem cell transplantation (HSCT); Leukemia; HIV Infections; Graft vs Host Disease; Myelodysplastic Syndromes; Coronavirus Disease 2019 (COVID-19); Precursor Cell Lymphoblastic Leukemia-Lymphoma; Dyslipidemias; Leukemia, Myeloid, Acute; Melanoma | Details |
Goflikicept | RPH-104 | Phase 3 Clinical | Trpharm | Still's Disease, Adult-Onset; Familial Mediterranean Fever; Myocardial Infarction; Schnitzler Syndrome; ST Elevation Myocardial Infarction; Coronavirus Disease 2019 (COVID-19); Pericarditis; Gout | Details |
Recombinant humanized monoclonal antibody antiIL-1β(Cp Guojian) | SSGJ-613 | Phase 3 Clinical | Sunshine GuoJian Pharmaceutical (Shanghai) Co Ltd | Tumor necrosis factor receptor associated periodic syndrome; Arthritis, Juvenile; Arthritis, Gouty; Gout; Inflammation | Details |
MAS-825 | MAS-825; MAS825 | Phase 3 Clinical | Novartis Pharmaceuticals Corp | Enterocolitis; Coronavirus Disease 2019 (COVID-19); Coronary Disease; Autoimmune Lymphoproliferative Syndrome | Details |
lutikizumab | ABT-981 | Phase 2 Clinical | Abbvie Inc | Osteoarthritis, Knee; Colitis, Ulcerative; Hidradenitis Suppurativa; Osteoarthritis | Details |
CU-06 | CU-06-EYE; CU-06-IBD; CU-061004; Sac-1004; CU-06-ONCO; CU-06-HAE; CU06-1004 | Phase 2 Clinical | Curacle Co Ltd | Myocardial Infarction; Neoplasms; Lung Diseases; Stroke; Diabetic macular oedema; Colitis, Ulcerative; Diabetic Retinopathy; Crohn Disease; Macular Degeneration; Angioedemas, Hereditary | Details |
IL1-beta receptor antagonist Therapy(Hamlet BioPharma) | Phase 2 Clinical | Hamlet BioPharma AB | Cystitis; Pain | Details | |
Diacerein (TWi Biotechnology/Castle Creek Pharmaceuticals) | AC-201; AC-201 Controlled release tablet; AC-201 CR; AC-203; CCP 020; CCP-020 | Phase 2 Clinical | Twi Biotechnology Inc | Diabetes Mellitus, Type 2; Epidermolysis Bullosa; Epidermolysis Bullosa Simplex; Pemphigoid, Bullous; Epidermolysis Bullosa, Junctional; Arthritis; Gout; Epidermolysis Bullosa Dystrophica | Details |
Gevokizumab | XMA-005.2; AB-7; XOMA-052; S-78989; VPM-087; XMA-0052 | Phase 1 Clinical | Xoma Corp | Colonic Neoplasms; Behcet Syndrome; Panuveitis; Labyrinth Diseases; Osteoarthritis; Uveitis; Colorectal Neoplasms; Cryopyrin-Associated Periodic Syndromes; Hereditary Autoinflammatory Diseases; Diabetes Mellitus, Type 1; Arthritis, Rheumatoid; Pyoderma Gangrenosum; Stomach Neoplasms; Carcinoma, Renal Cell; Esophageal Neoplasms; Diabetes Mellitus, Type 2; Acne Vulgaris | Details |
DLX-2323 | DLX-2323 | Phase 1 Clinical | Delenex Therapeutics Ag | Inflammation | Details |
Tavo-103 | Tavo103; Tavo-103; TAVO-103A; TAVO103A | Phase 1 Clinical | Tavotek Biotherapeutics (Hong Kong) Ltd | Details | |
FL-101 | FL-101 | Phase 1 Clinical | Flame Biosciences Inc | Urinary Bladder Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
AK-114 | AK-114; AK114 | Phase 1 Clinical | Zhongshan Akeso Biopharma Co Ltd | Solid tumours; Neoplasms; Inflammation; Neoplasm Metastasis | Details |
This web search service is supported by Google Inc.